Early research (Phase 1)Study completedNCT00002936What this trial is testingAltretamine and Etoposide in Treating Patients With HIV-Related CancerWho this might be right forLymphomaSarcoma Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT01376349What this trial is testingPrasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal SymptomsWho this might be right forBreast CancerGynecologic Cancer Alliance for Clinical Trials in Oncology 464
Large-scale testing (Phase 3)Study completedNCT00131898What this trial is testingA Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal SarcomaWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 150
Not applicableStudy completedNCT01841047What this trial is testingAssessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal LiposarcomaWho this might be right forLiposarcoma Institut Bergonié 48
Not applicableNot Yet RecruitingNCT06500715What this trial is testingAcupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With SarcomaWho this might be right forFebrile NeutropeniaSarcomaDoxorubicin Adverse Reaction+1 more Shaare Zedek Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT03997968What this trial is testingCYT-0851 in B-Cell Malignancies and Advanced Solid TumorsWho this might be right forMalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more Cyteir Therapeutics, Inc. 169
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00719849What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Fred Hutchinson Cancer Center 13
Not applicableLooking for participantsNCT06324916What this trial is testingDonor Site Morbidity After Free Vascularized Fibular GraftWho this might be right forOsteosarcoma Assiut University 20
Testing effectiveness (Phase 2)Study completedNCT00024258What this trial is testingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more Memorial Sloan Kettering Cancer Center 22
Not applicableEnded earlyNCT00582608What this trial is testingTumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9Who this might be right forCNS CancerNeuroblastomaSarcoma Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868What this trial is testingAPG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsWho this might be right forUnresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more Ascentage Pharma Group Inc. 230
Early research (Phase 1)Study completedNCT01859026What this trial is testingA Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationWho this might be right forLung CancerNon-Small Cell Lung Cancer H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03997747What this trial is testingCancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OSWho this might be right forOsteosarcoma Peking University People's Hospital 38
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Testing effectiveness (Phase 2)Study completedNCT01347034What this trial is testingRadiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)Who this might be right forSoft Tissue Sarcoma H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00887809What this trial is testingGemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesWho this might be right forSarcomaLeiomyosarcomaMalignant Fibrous+2 more Memorial Sloan Kettering Cancer Center 47